跳至主要内容
临床试验/NCT06010641
NCT06010641招募中不适用

Trendelenburg Position for Acute Anterior Circulation Ischemic Stroke With Large Artery Atherosclerosis Etiology (HOPES 3): a Prospective, Randomized, Open-label, Blinded-endpoint, Multi-center Trial

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
600
试验地点
1
主要终点
proportion of favorable functional outcome

研究概览

简要总结

The effect of head position as a nonpharmacological therapy on acute ischemic stroke (AIS) remains inconclusive. Recent HOPES2 (Head dOwn-Position for acutE moderate ischemic Stroke with large artery atherosclerosis) suggest the safety, feasibility, and potential benefit of the head-down position (HDP) in acute ischemic stroke. The current study aims to investigate the efficacy and safety of HDP in acute moderate ischemic stroke patients with large artery atherosclerosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years old
  • Acute ischemic stroke confirmed by NCCT or MRI;
  • Moderate neurologic deficit (6≤ NIHSS ≤ 16) within 24 hours of onset, or progressing from mild (NIHSS ≤ 5) to moderate neurologic deficit (6≤ NIHSS ≤ 16) within 24 hours, requiring ≥ 4 point increase in NIHSS score although the onset time is beyond 24 hours;
  • Probable large artery atherosclerosis etiology based on the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria (responsible artery stenosis ≥ 50% or occlusion);
  • Anterior circulation stroke (internal carotid artery, M1 or M2 of middle cerebral artery);
  • First stroke onset or past stroke without obvious neurological deficit (mRS≤2);
  • Signed informed consent.

排除标准

  • Pre-stroke disability (mRS≥3);
  • Patients with disturbance of consciousness;
  • Patients who plan to undergo or have completed thrombolysis or mechanical thrombectomy;
  • Hemorrhagic stroke or combined ischemic and hemorrhagic stroke;
  • Serious comorbidity, such as liver or kidney insufficiency, malignant tumor, etc;
  • Other stroke etiologies, such as cardiogenic embolism, arteritis, arterial dissection, moyamoya disease, etc;
  • Previous history of intracerebral hemorrhage within 1 year;
  • Any contraindication to head-down position (e.g. active vomiting, pneumonia, uncontrolled heart failure);
  • Planned carotid or intracranial revascularization within 3 months;
  • Severe uncontrolled hypertension (systolic blood pressure over 180mmHg or diastolic blood pressure over 100 mmHg);
  • Cardiac insufficiency (NYHA Class ≥II);
  • Pregnant or lactating women;
  • Comorbidity with other serious diseases;
  • Participating in other clinical trials within 3 months;
  • Patients not suitable for the study considered by researcher.

研究组 & 干预措施

Head-down position

Experimental

head-down position as an adjunct to guideline-based treatment

干预措施: head-down position (Other)

control

Other

guideline-based treatment

干预措施: head-down position (Other)

结局指标

主要结局

proportion of favorable functional outcome

时间窗: 90±7 days

favorable functional outcome defined as modified Rankin Score (mRS) 0-2. The minimum and maximum values of mRS are 0 and 6, respectively; higher score mean a worse outcome

次要结局

  • new stroke or other vascular event(s)(90±7 days)
  • early neurological deterioration (END)(48±12 hours)
  • changes in infarct volume(48±12 hours)
  • proportion of excellent functional outcome(90±7 days)
  • ordinal distribution of modified Rankin Score (mRS)(90±7 days)
  • early neurological improvement (ENI)(48±12 hours)
  • Changes in National Institute of Health stroke scale (NIHSS)(10±2 days)
  • all-cause mortality(90±7 days)
  • Changes in National Institute of Health stroke scale (NIHSS)(48±12 hours)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Director

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验